title: Less-tight versus tight control of hypertension in pregnancy.
abstract: BACKGROUND
  The effects of less-tight versus tight control of hypertension on pregnancy complications are unclear.
  
  
  METHODS
  We performed an open, international, multicenter trial involving women at 14 weeks 0 days to 33 weeks 6 days of gestation who had nonproteinuric preexisting or gestational hypertension, office diastolic blood pressure of 90 to 105 mm Hg (or 85 to 105 mm Hg if the woman was taking antihypertensive medications), and a live fetus. Women were randomly assigned to less-tight control (target diastolic blood pressure, 100 mm Hg) or tight control (target diastolic blood pressure, 85 mm Hg). The composite primary outcome was pregnancy loss or high-level neonatal care for more than 48 hours during the first 28 postnatal days. The secondary outcome was serious maternal complications occurring up to 6 weeks post partum or until hospital discharge, whichever was later.
  
  
  RESULTS
  Included in the analysis were 987 women; 74.6% had preexisting hypertension. The primary-outcome rates were similar among 493 women assigned to less-tight control and 488 women assigned to tight control (31.4% and 30.7%, respectively; adjusted odds ratio, 1.02; 95% confidence interval [CI], 0.77 to 1.35), as were the rates of serious maternal complications (3.7% and 2.0%, respectively; adjusted odds ratio, 1.74; 95% CI, 0.79 to 3.84), despite a mean diastolic blood pressure that was higher in the less-tight-control group by 4.6 mm Hg (95% CI, 3.7 to 5.4). Severe hypertension (≥160/110 mm Hg) developed in 40.6% of the women in the less-tight-control group and 27.5% of the women in the tight-control group (P<0.001).
  
  
  CONCLUSIONS
  We found no significant between-group differences in the risk of pregnancy loss, high-level neonatal care, or overall maternal complications, although less-tight control was associated with a significantly higher frequency of severe maternal hypertension. (Funded by the Canadian Institutes of Health Research; CHIPS Current Controlled Trials number, ISRCTN71416914; ClinicalTrials.gov number, NCT01192412.).
authors: From the Departments of Medicine (L.A.M.) and Obstetrics and Gynaecology (L.A.M., P.D., J.M.), the School of Population and Public Health (L.A.M., P.D., J. Singer), and the Centre for Health Evaluation and Outcome Sciences, Providence Health Care Research Institute (J. Singer, T.L.), University of British Columbia, Vancouver; the Departments of Medicine and Obstetrics and Gynaecology, University of Montreal, Montreal (E.R.); the Department of Obstetrics and Gynaecology, University of Alberta, Edmonton (S.R.); the Departments of Obstetrics and Gynaecology (E.A., K.E.M.), Paediatrics (E.A., S.K.L.), and Medicine (A.G.L.) and the Centre for Mother, Infant, and Child Research, Sunnybrook Research Institute (E.A., K.E.M., J. Sanchez), University of Toronto, Toronto; the Departments of Clinical Epidemiology and Biostatistics (A. Gafni) and Obstetrics and Gynaecology (E.H.), McMaster University, Hamilton, ON; the Department of Obstetrics and Gynaecology, University of Ottawa, Ottawa (A. Gruslin); the Department of Obstetrics and Gynaecology, University of Manitoba, Winnipeg (M.H.); and the Department of Obstetrics and Gynaecology, Université de Sherbrooke, Sherbrooke, QC (J.-M.M.) - all in Canada; the Department of Obstetrics and Gynecology, University of Amsterdam, Amsterdam (W.G.); and the Department of Obstetrics and Gynaecology, Derriford Hospital, Devon (R.W.), and the Department of Obstetrics and Gynaecology, University of Nottingham, Nottingham (J.G.T.) - both in the United Kingdom.
authors: Laura A
authors: LA
authors: Magee
authors: Peter
authors: P
authors: von Dadelszen
authors: Evelyne
authors: E
authors: Rey
authors: Susan
authors: S
authors: Ross
authors: Elizabeth
authors: E
authors: Asztalos
authors: Kellie E
authors: KE
authors: Murphy
authors: Jennifer
authors: J
authors: Menzies
authors: Johanna
authors: J
authors: Sanchez
authors: Joel
authors: J
authors: Singer
authors: Amiram
authors: A
authors: Gafni
authors: Andrée
authors: A
authors: Gruslin
authors: Michael
authors: M
authors: Helewa
authors: Eileen
authors: E
authors: Hutton
authors: Shoo K
authors: SK
authors: Lee
authors: Terry
authors: T
authors: Lee
authors: Alexander G
authors: AG
authors: Logan
authors: Wessel
authors: W
authors: Ganzevoort
authors: Ross
authors: R
authors: Welch
authors: Jim G
authors: JG
authors: Thornton
authors: Jean-Marie
authors: JM
authors: Moutquin
mesh_terms: D000022:Abortion, Spontaneous / Q000209:etiology; D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006801:Humans; D046110:Hypertension, Pregnancy-Induced / Q000188:drug therapy*; D007231:Infant, Newborn; D015931:Intensive Care, Neonatal / Q000706:statistics & numerical data; D066087:Perinatal Death / Q000209:etiology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology / Q000209:etiology*; D011256:Pregnancy Outcome; D011644:Puerperal Disorders / Q000209:etiology
chemical_list: D000959:Antihypertensive Agents